Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK's MMR Vaccine (Priorix) vs Merck's MMR Vaccine in Healthy Children
NCT02184572Phase 3Completed
- Sponsor
- GSK
- Start
- Aug 2014
- Primary completion
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of measles, mumps and rubella vaccine (live) in measles, mumps, rubella, sponsored by GSK. Started Aug 2014; status: completed.
02
Drugs
measles, mumps and rubella vaccine (live)
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT02184572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02184572.